Mereo BioPharma Group Plc (MREO)

0.3486 +0.01 (+3.29%) USD  |  NASDAQ  |  Sep 25, 15:48
More

Mereo BioPharma Group Cash from Investing (Quarterly) : -0.0004M for June 30, 2026

Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 -0.0004M
March 31, 2026 -0.2995M
December 31, 2025 0.00
September 30, 2025 0.3027M
June 30, 2025 -0.0015M
Date Value
March 31, 2025 -0.3212M
December 31, 2024 0.0028M
September 30, 2024 -0.0029M
June 30, 2024 0.0004M
March 31, 2024 -0.6996M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
NuCana Plc -0.0453M
BioNTech SE -118.82M
Silence Therapeutics Plc 64.78M
Compass Pathways Plc 0.00

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly) -6.048M
Free Cash Flow -25.58M
Free Cash Flow Per Share (Quarterly) -0.0376
Free Cash Flow to Equity (Quarterly) -7.079M
Free Cash Flow to Firm (Quarterly) -6.049M
Free Cash Flow Yield -45.84%